National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
Eur J Clin Invest. 2024 May;54(5):e14161. doi: 10.1111/eci.14161. Epub 2024 Jan 18.
The metabolically healthy obese (MHO) phenotype is associated with an increased risk of coronary heart disease (CHD) in the general population. However, association of metabolic health and obesity phenotypes with CHD risk in adult cancer survivors remains unclear. We aimed to investigate the associations between different metabolic health and obesity phenotypes with incident CHD in adult cancer survivors.
We used National Health Insurance Service (NHIS) to identify a cohort of 173,951 adult cancer survivors aged more than 20 years free of cardiovascular complications. Metabolically healthy nonobese (MHN), MHO, metabolically unhealthy nonobese (MUN), metabolically unhealthy obese (MUO) phenotypes were created using as at least three out of five metabolic health criteria along with obesity (body mass index ≥ 25.0 kg/m). We used Cox proportional hazards model to assess CHD risk in each metabolic health and obesity phenotypes.
During 1,376,050 person-years of follow-up, adult cancer survivors with MHO phenotype had a significantly higher risk of CHD (hazard ratio [HR] = 1.52; 95% confidence intervals [CI]: 1.41 to 1.65) as compared to those without obesity and metabolic abnormalities. MUN (HR = 1.81; 95% CI: 1.59 to 2.06) and MUO (HR = 1.92; 95% CI: 1.72 to 2.15) phenotypes were also associated with an increased risk of CHD among adult cancer survivors.
Adult cancer survivors with MHO phenotype had a higher risk of CHD than those who are MHN. Metabolic health status and obesity were jointly associated with CHD risk in adult cancer survivors.
代谢健康型肥胖(MHO)表型与普通人群的冠心病(CHD)风险增加有关。然而,代谢健康和肥胖表型与成年癌症幸存者 CHD 风险的关系尚不清楚。我们旨在研究不同的代谢健康和肥胖表型与成年癌症幸存者发生 CHD 的相关性。
我们使用国家健康保险服务(NHIS)确定了一个由 173951 名年龄在 20 岁以上且无心血管并发症的成年癌症幸存者组成的队列。代谢健康非肥胖(MHN)、MHO、代谢不健康非肥胖(MUN)和代谢不健康肥胖(MUO)表型是通过至少三项代谢健康标准和肥胖(BMI≥25.0kg/m)来确定的。我们使用 Cox 比例风险模型评估每种代谢健康和肥胖表型的 CHD 风险。
在 1376050 人年的随访期间,与无肥胖和代谢异常的患者相比,MHO 表型的成年癌症幸存者患 CHD 的风险显著更高(风险比 [HR] = 1.52;95%置信区间 [CI]:1.41 至 1.65)。MUN(HR = 1.81;95% CI:1.59 至 2.06)和 MUO(HR = 1.92;95% CI:1.72 至 2.15)表型也与成年癌症幸存者的 CHD 风险增加相关。
与 MHN 相比,MHO 表型的成年癌症幸存者患 CHD 的风险更高。代谢健康状况和肥胖与成年癌症幸存者的 CHD 风险相关。